Clinical Trials Browser

Recurrence × veliparib × Clear all

NCT01193140 2012-11-21

To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subjects With Solid Tumors

Phase 2 Completed

Neoplasms, Recurrence